<DOC>
	<DOCNO>NCT00228319</DOCNO>
	<brief_summary>The purpose study try understand add benefit increase harm antioxidant nutritional supplement add traditional chemotherapy treatment ovarian cancer .</brief_summary>
	<brief_title>Treatment Newly Diagnosed Ovarian Cancer With Antioxidants</brief_title>
	<detailed_description>The subject randomize 2 study group . Group 1 receive standard chemotherapy prescribe cancer doctor ( carboplatin paclitaxel ) possible choice extend chemotherapy additional 12 month . Group 2 receive standard chemotherapy manner group 1 . In addition , receive 12 month oral IV nutritional supplement .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Carotenoids</mesh_term>
	<criteria>histologically confirm carcinoma ovary stage III IV measurable assessable disease drug refractory ovarian cancer must 18 year age must parental consent enroll study must ambulatory evidence significant psychiatric disorder history exam consumption excess alcohol ( 4 follow per day : 30 ml distil spirit , 340 ml beer , 120 ml wine ) recreational drug tobacco use prior treatment investigational drug , chemo , radiation therapy , hormonal therapy within preceeding month pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>